I guess it depends on whether Big Pharma really wants to conquer the disease or just treat symptoms. It seems more a business than a humanitarian decision. There are some drugs that actually do conquer a disease. Most do not. I think Anavex is seeking to halt or even reverse this ravaging disease. My hat is off to them.
This is an interesting read that may shed light on why results are not yet available. wwwDOTanavexDOTcom/?news=anavex-to-participate-in-phase-3-clinical-trials-panel-at-adpd-2015
Unlike Eli Lilly, our endpoints remain unchanged:
Kristina Capiak Anavex Life Science Corp.
Posted: 03 Mar 2016
The protocol or trial design or entry criteria were never changed after trial approval by the ethics committee, with the exception of extending Part B from 26 to 52 weeks.
You seem to be a glutton for spreading misinformation and you can't even get a 60 on your final spelling exam. You fail.
2 morons. Why don't you short today if you think it's going to the mid-threes. That would be a good profit for you. Go for it.
It would be nice if the results were so good that the trial was halted and the FDA gives immediate conditional approval. Phase 3 could be started along with conditional approval and those on Anavex 2-73 would continue in Phase 3. It has been done before.
Smart people learn from their own mistakes. Wise people learn from the mistakes of others. Thanks for increasing my wisdom. I'm here for the long term.
Medical docs aren't looking for a cure, IMO. Alziheimers is a cash cow for their business. I hope, for the sake of the victims of Alzheimers, that a cure is on the horizon.
Either folks believe in the science or they don't. Seems some don't. Maybe they shouldn't invest here. I'm in at 27 cents and have no intention of selling anytime soon. So, I guess you could say I believe in the science. All indications look like this probably stops and possibly reverses Alzheimer's Disease. There's always a risk but I think McFarlane's enthusiasm is coming from the results he sees and not a p&d. Just my opinion.
Hello Peter. I plan to hold for at least a year so my capital gains tax will be around 15% instead of close to 30%. In addition to that, I believe in the science and realize the sky is the limit on this investment. This stock is way underpriced right now. It is hard to put a value on it because there are a lot of drugs in its pipeline. These are drugs that could potentially be worth billions of dollars. Our management team is top notch. The folks we have on board wouldn't be there if they didn't believe in the science. Congratulations on finding this gem in your early investing career
"The MJFF grant is expected to fully fund a preclinical study on the effect of ANAVEX 2-73 in a Parkinson’s disease animal model, which seeks to provide a solid dataset that will justify moving forward to clinical development in Parkinson’s. "
Nice try anny
This stock is a Buy and Hold now. A simple math equasion: the less shares available for sale, the higher the price. I think it's called supply and demand.
Agreed 100%. Wait until AVXL reaches $20.00 then we'll talk. Don't forget the Epilepsy indication and several others.